Industry News
MiddleBrook Pharmaceuticals, Inc. Secures $10 Million Revolving Line of Credit
Tuesday, June 30th, 2009Spectrum Pharmaceuticals, Inc. to Raise $21 Million from Institutional Investors at $7.1525 Per Share
Tuesday, June 30th, 2009Charles River Laboratories (Massachusetts) Announces RMS Succession Plan and Organizational Enhancements
Tuesday, June 30th, 2009Europe Approves AstraZeneca PLC Lung Cancer Drug
Tuesday, June 30th, 2009Biogen Idec, Inc. (Massachusetts) Gains Rights to Acorda Therapeutics’s MS Drug; to Get $110 Million Up Front
Tuesday, June 30th, 2009UCB Group and Biogen Idec, Inc. (Massachusetts) Discontinue Phase II Clinical Trial of CDP323
Tuesday, June 30th, 2009Novartis Corporation Sees FDA Decision on Menveo Early 2010 US After Regulator Seeks More Data on Meningitis Vaccine
Tuesday, June 30th, 2009U.S. FDA Casts Doubt on Lantus Cancer Link
Tuesday, June 30th, 2009ProCertus BioPharm, Inc. Raises $2.1 Million
Tuesday, June 30th, 2009
pehub.com -- ProCertus BioPharm Inc., a Madison, Wisc.-based developer of drugs to treat the side effects of chemotherapy and radiotherapy on cancer patients, has raised $2.1 million in new VC funding. Return backers include Novartis Venture Fund and Venture Investors LLC.